ELVN logo

Enliven Therapeutics, Inc. (ELVN) Operating Profit

Annual Operating Profit:

-$104.55M-$21.02M(-25.17%)
December 31, 2024

Summary

  • As of today, ELVN annual operating income is -$104.55 million, with the most recent change of -$21.02 million (-25.17%) on December 31, 2024.
  • During the last 3 years, ELVN annual operating profit has fallen by -$79.79 million (-322.24%).
  • ELVN annual operating profit is now -1074.10% below its all-time high of -$8.90 million, reached on December 1, 2017.

Performance

ELVN Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherELVNincome statement metrics

Quarterly Operating Profit:

-$25.10M+$3.49M(+12.20%)
September 30, 2025

Summary

  • As of today, ELVN quarterly operating income is -$25.10 million, with the most recent change of +$3.49 million (+12.20%) on September 30, 2025.
  • Over the past year, ELVN quarterly operating profit has increased by +$1.97 million (+7.29%).
  • ELVN quarterly operating profit is now -670.53% below its all-time high of -$3.26 million, reached on December 31, 2022.

Performance

ELVN Quarterly Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherELVNincome statement metrics

TTM Operating Profit:

-$112.27M+$1.97M(+1.73%)
September 30, 2025

Summary

  • As of today, ELVN TTM operating income is -$112.27 million, with the most recent change of +$1.97 million (+1.73%) on September 30, 2025.
  • Over the past year, ELVN TTM operating profit has dropped by -$11.88 million (-11.84%).
  • ELVN TTM operating profit is now -1531.34% below its all-time high of -$6.88 million, reached on September 1, 2019.

Performance

ELVN TTM Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherELVNincome statement metrics

Operating Profit Formula

Operating Profit = Gross Profit − Operating Expenses

ELVN Operating Profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-25.2%+7.3%-11.8%
3Y3 Years-322.2%-129.5%-161.3%
5Y5 Years-333.6%-100.9%-272.4%

ELVN Operating Profit Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-322.2%at low-670.5%+20.8%-252.1%+1.7%
5Y5-Year-333.6%at low-670.5%+20.8%-272.4%+1.7%
All-TimeAll-Time-1074.1%at low-670.5%+20.8%-1531.3%+1.7%

ELVN Operating Profit History

DateAnnualQuarterlyTTM
Sep 2025
-
-$25.10M(+12.2%)
-$112.27M(+1.7%)
Jun 2025
-
-$28.58M(+9.8%)
-$114.24M(-3.6%)
Mar 2025
-
-$31.69M(-17.8%)
-$110.26M(-5.5%)
Dec 2024
-$104.55M(-25.2%)
-$26.90M(+0.6%)
-$104.55M(-4.2%)
Sep 2024
-
-$27.07M(-10.0%)
-$100.39M(-2.9%)
Jun 2024
-
-$24.60M(+5.3%)
-$97.57M(-4.8%)
Mar 2024
-
-$25.99M(-14.3%)
-$93.10M(-11.5%)
Dec 2023
-$83.53M(-143.7%)
-$22.73M(+6.3%)
-$83.53M(-30.4%)
Sep 2023
-
-$24.25M(-20.4%)
-$64.06M(-26.2%)
Jun 2023
-
-$20.13M(-22.6%)
-$50.74M(-28.1%)
Mar 2023
-
-$16.42M(-404.1%)
-$39.63M(-24.3%)
Dec 2022
-$34.27M
-$3.26M(+70.2%)
-$31.89M(+25.8%)
Sep 2022
-
-$10.93M(-21.3%)
-$42.96M(+6.0%)
Jun 2022
-
-$9.02M(-3.9%)
-$45.69M(+8.3%)
DateAnnualQuarterlyTTM
Mar 2022
-
-$8.68M(+39.5%)
-$49.84M(+3.1%)
Dec 2021
-$24.76M(+40.6%)
-
-
Dec 2021
-
-$14.33M(-4.9%)
-$51.44M(-5.7%)
Sep 2021
-
-$13.66M(-3.7%)
-$48.66M(-2.5%)
Jun 2021
-
-$13.17M(-28.1%)
-$47.49M(-6.4%)
Mar 2021
-
-$10.28M(+11.0%)
-$44.63M(-7.0%)
Dec 2020
-$41.70M(-72.9%)
-$11.55M(+7.6%)
-$41.70M(-38.3%)
Sep 2020
-
-$12.49M(-21.3%)
-$30.15M(-22.9%)
Jun 2020
-
-$10.30M(-40.1%)
-$24.54M(-72.4%)
Mar 2020
-
-$7.35M(-6.8%)
-$14.23M(-106.8%)
Dec 2019
-$24.12M(-125.9%)
-
-
Sep 2019
-
-$6.88M
-$6.88M
Dec 2018
-$10.68M(-19.9%)
-
-
Dec 2017
-$8.90M
-
-

FAQ

  • What is Enliven Therapeutics, Inc. annual operating income?
  • What is the all-time high annual operating profit for Enliven Therapeutics, Inc.?
  • What is Enliven Therapeutics, Inc. annual operating profit year-on-year change?
  • What is Enliven Therapeutics, Inc. quarterly operating income?
  • What is the all-time high quarterly operating profit for Enliven Therapeutics, Inc.?
  • What is Enliven Therapeutics, Inc. quarterly operating profit year-on-year change?
  • What is Enliven Therapeutics, Inc. TTM operating income?
  • What is the all-time high TTM operating profit for Enliven Therapeutics, Inc.?
  • What is Enliven Therapeutics, Inc. TTM operating profit year-on-year change?

What is Enliven Therapeutics, Inc. annual operating income?

The current annual operating profit of ELVN is -$104.55M

What is the all-time high annual operating profit for Enliven Therapeutics, Inc.?

Enliven Therapeutics, Inc. all-time high annual operating income is -$8.90M

What is Enliven Therapeutics, Inc. annual operating profit year-on-year change?

Over the past year, ELVN annual operating income has changed by -$21.02M (-25.17%)

What is Enliven Therapeutics, Inc. quarterly operating income?

The current quarterly operating profit of ELVN is -$25.10M

What is the all-time high quarterly operating profit for Enliven Therapeutics, Inc.?

Enliven Therapeutics, Inc. all-time high quarterly operating income is -$3.26M

What is Enliven Therapeutics, Inc. quarterly operating profit year-on-year change?

Over the past year, ELVN quarterly operating income has changed by +$1.97M (+7.29%)

What is Enliven Therapeutics, Inc. TTM operating income?

The current TTM operating profit of ELVN is -$112.27M

What is the all-time high TTM operating profit for Enliven Therapeutics, Inc.?

Enliven Therapeutics, Inc. all-time high TTM operating income is -$6.88M

What is Enliven Therapeutics, Inc. TTM operating profit year-on-year change?

Over the past year, ELVN TTM operating income has changed by -$11.88M (-11.84%)
On this page